Navigation Links
Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology
Date:10/4/2010

an EGFR inhibitor based on KRAS status in patients with previously treated mCRC.

Results from both trials were previously presented at Europe's largest cancer conference, ECCO 15 – ESMO 34, in September 2009, at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in January, and at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in June.

About the PRIME '203' TrialPatients enrolled in the '203' or PRIME trial (Panitumumab Randomized trial In combination with chemotherapy for Metastatic colorectal cancer to determine Efficacy) were randomized to receive either 6.0 mg/kg of Vectibix and FOLFOX4 once every two weeks (Q2W) or FOLFOX4 alone Q2W. The primary endpoint of the study was progression-free survival by KRAS status and secondary endpoints included overall survival, objective response rate, time to progression, duration of response and safety. Long-term follow up for overall survival is ongoing.

About the '181' Trial The '181' trial is a global, multicenter, randomized Phase 3 study. Patients enrolled in the study were randomized to receive either 6.0 mg/kg of Vectibix and FOLFIRI Q2W or FOLFIRI alone Q2W. The co-primary endpoints were progression-free survival (which was independently tested) and overall survival. Secondary endpoints included objective response rate, time to progression, duration of response and safety by KRAS status.

About KRASResults from studies performed over the last 25 years indicate that KRAS plays an important role in cell growth regulation. In mCRC, EGFR transmits signals through a set of intracellular proteins. Upon reaching the nucleus, these signals instruct the cancer cell to reproduce and metastasize, leading to cancer progression. Anti-EGFR antibody therapies work by inhibiting the activation of EGFR, thereby inhibiting downstream events that lead to malignant signaling. However, in patien
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
2. Positive SPA Reply From the FDA for TopoTargets Pivotal Trial With Belinostat in PTCL
3. Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
4. Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial
5. Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
7. BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
8. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
9. ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... 2015 , ... Visual Assay was named as a finalist for the 53rd ... and services of the past year. More than 70 judges selected the finalists, including ... be announced at the 2015 R&D 100 Awards Dinner on November 13 at Caesars ...
(Date:7/24/2015)... , July 24, 2015 Ryan & ... filed in United States District Court for the Northern District ... persons or entities that purchased the common stock of Avalanche ... between July 31, 2014 and June 15, 2015, inclusive (the ... September 8, 2015, move the Court for appointment as a ...
(Date:7/24/2015)... 24, 2015  Champions Oncology (OTC-BB: CSBR), a company ... services to personalize the development and use of oncology ... operational results for the fourth quarter and fiscal year ... 2015, before market open. The company will ... day at 9:00 a.m. EDT (6:00 a.m. PDT). To ...
(Date:7/24/2015)... 2015 The global next ... 27.8 billion by 2022, growing at an estimated CAGR ... new study by Grand View Research, Inc. Development of ... result in significant reduction in cost of sequencing one ... usage rates of next generation sequencing throughout the forecast ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... only one-tenth the size of a human hair, but ... the intense heat and radiation of next generation nuclear ... power-generating reactors are being designed to provide low-cost electricity, ... not have. , The Department of Energy (DoE) ...
... Research &,Instrumentation, Inc. (CRi) announces the launch of ... brightfield or,fluorescent microscope into a multispectral imaging workstation. ... as embryos,zebrafish, plants, tissue culture and microtiter plates, ... macroscope. The Nuance 2 system will be,showcased at ...
... Inc. (OTC,Bulletin Board: SCIE) announced today that Jim Dorst ... and Chief Financial Officer., Jim Hitchin the Company,s ... of,experience in public medical device, manufacturing and software firms. ... ago. With a graduate,degree in accounting, he is well ...
Cached Biology Technology:Clemson researcher studies carbon fibers for nuclear reactor safety 2CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy 2Jim Dorst Joins SpectraScience as CFO 2
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Thanks to a single-molecule imaging technique developed by ... mechanisms of an important DNA-regulating enzyme. Helicase enzymes ... have many other functions for DNA repair and maintenance. ... called PcrA involved in preventing unwanted recombination. A ...
... lipids and carbohydrates during exercise. The carbohydrates consist of ... glucose extracted from the blood. Being a major sink ... tissue for studying the intracellular signaling pathways leading to ... it is known that the contraction-induced signaling to stimulate ...
... University School of Medicine (BUSM) report that physicians who use ... on patients with an abnormal Pap test could increase the ... achieve resolution in less time than using traditional methods. These ... . Screening for cervical cancer with a Pap ...
Cached Biology News:Researchers advance understanding of enzyme that regulates DNA 2New molecular signaling cascade increases glucose uptake 2Electronic tracking system can improve follow-up after an abnormal Pap test 2
... Detergent Clean-up Micro Kit provides a fast and ... Triton X-100 and other detergents from small samples ... Norgens patented protein resin as an ion exchanger. ... g of either acidic or basic protein.A complete ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
... cells form from a hematopoietic stem cells ... to the bone surface and lowering the ... around 4.5. The bone mineral is then ... and function is controlled primarily by Macrophage ...
Values of steady state parameters for enzyme activities are determined....
Biology Products: